Dilip Shanghvi was bornon 1 October 1955 in Amreli, Gujarat, India, India. Dilip Shanghvi is #114 in List Billionaires People In The World. He founded Sun Pharmaceutical Industries and serves as managing director. The son of a pharmaceuticals distributor, he borrowed $200 from his father to start Sun in 1983 to make psychiatric drugs. The company is the world's fifth largest generics maker and India's most valuable pharma outfit with 2016 revenues of $4.1 billion He grew Sun through a series of shrewd acquisitions, the biggest of which was the purchase of scandal-tainted rival Ranbaxy Laboratories for $4 billion in 2014. His fortune has declined two years in a row as Sun's shares fell after the U.S. Food and Drug Administration observed manufacturing lapses at one of its biggest factories in India.
Our story is all about incremental growth. We"re not looking for big leaps; we prefer small jumps.
India Today magazine ranked him #8th in India's 50 Most powerful people of 2017 list
The Government of India awarded him the civilian honour of the Padma Shri in 2016
2B in Sun stock and that Sun would take on $800M in Ranbaxy debt; the deal closed in March 2015 and made Sun the largest drug company in India and the fifth largest in the world, and made Daiichi the second largest shareholder in Sun
Shanghvi stepped down as Chairman and CEO in 2012 and chose Israel Makov, formerly CEO of Teva Pharmaceuticals, as his successor; Shangvi became Managing Director
In 1997, Sun acquired Caraco Pharma, a loss-making American company, with the aim of expanding Sun's reach in the United States
Dilip Shanghvi started Sun Pharmaceutical Industries with capital of ₹10,000 in 1982 at Vapi, with one psychiatry drug and a partner, Pradeep Ghosh
Dilip Shanghvi (born 1 October 1955) is an Indian businessman and one of the country's richest people